Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1911 1
1931 1
1933 1
1934 1
1935 2
1938 2
1941 1
1942 1
1945 17
1946 28
1947 77
1948 99
1949 86
1950 121
1951 168
1952 205
1953 208
1954 192
1955 170
1956 268
1957 371
1958 397
1959 354
1960 372
1961 415
1962 506
1963 664
1964 782
1965 671
1966 558
1967 679
1968 683
1969 786
1970 712
1971 700
1972 679
1973 670
1974 692
1975 614
1976 780
1977 699
1978 662
1979 825
1980 748
1981 824
1982 798
1983 860
1984 923
1985 986
1986 1000
1987 1031
1988 1146
1989 1300
1990 1367
1991 1224
1992 1406
1993 1367
1994 1410
1995 1455
1996 1529
1997 1559
1998 1607
1999 1798
2000 1797
2001 1750
2002 1864
2003 2159
2004 2156
2005 2439
2006 2654
2007 2905
2008 3070
2009 3335
2010 3568
2011 3757
2012 4078
2013 4293
2014 4822
2015 5114
2016 4843
2017 4917
2018 5161
2019 5649
2020 6126
2021 1308
Text availability
Article attribute
Article type
Publication date

Search Results

110,689 results
Results by year
Filters applied: . Clear all
Page 1
Cervical cancer: screening, diagnosis and staging.
Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A, Galazios G. Tsikouras P, et al. J BUON. 2016 Mar-Apr;21(2):320-5. J BUON. 2016. PMID: 27273940 Free article. Review.
Even if cervical HPV infection is incredibly common, cervical cancer is relatively rare. ...The treatment of cervical cancer is based on the FIGO 2009 cervical cancer staging....
Even if cervical HPV infection is incredibly common, cervical cancer is relatively rare. ...The treatment of cervica …
Human Papilloma Virus-Associated Cervical Cancer and Health Disparities.
Olusola P, Banerjee HN, Philley JV, Dasgupta S. Olusola P, et al. Cells. 2019 Jun 21;8(6):622. doi: 10.3390/cells8060622. Cells. 2019. PMID: 31234354 Free PMC article. Review.
Periodic surveillance through hrHPV and Pap smear-based testing has remarkably reduced cervical cancer incidence worldwide and in the USA. However, considerable discordance in the occurrence and outcome of cervical cancer in various populations exists. …
Periodic surveillance through hrHPV and Pap smear-based testing has remarkably reduced cervical cancer incidence worldwide and …
Human papillomavirus and cervical cancer.
Burd EM. Burd EM. Clin Microbiol Rev. 2003 Jan;16(1):1-17. doi: 10.1128/cmr.16.1.1-17.2003. Clin Microbiol Rev. 2003. PMID: 12525422 Free PMC article. Review.
The association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well established. Although HPV is essential to the transformation of cervical epithelial cells, it is not sufficient, and a variety of cofactors and molecular events i …
The association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well established. Although HPV is …
Epigenetics and cervical cancer: from pathogenesis to therapy.
Fang J, Zhang H, Jin S. Fang J, et al. Tumour Biol. 2014 Jun;35(6):5083-93. doi: 10.1007/s13277-014-1737-z. Epub 2014 Feb 20. Tumour Biol. 2014. PMID: 24554414 Review.
Although human papillomavirus (HPV) infection has been found in most of the cervical cancer cases, additional genetic and epigenetic changes are required for disease progression. Previously, it was thought that only genetic mutation plays a key role in cervical …
Although human papillomavirus (HPV) infection has been found in most of the cervical cancer cases, additional genetic and epig …
The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.
Hu Z, Ma D. Hu Z, et al. Cancer Med. 2018 Oct;7(10):5217-5236. doi: 10.1002/cam4.1501. Epub 2018 Sep 14. Cancer Med. 2018. PMID: 30589505 Free PMC article. Review.
Cervical cancer is the third most common cancer in women worldwide, with concepts and knowledge about its prevention and treatment evolving rapidly. Human papillomavirus (HPV) has been identified as a major factor that leads to cervical cancer, …
Cervical cancer is the third most common cancer in women worldwide, with concepts and knowledge about its prevention an …
Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
Marquina G, Manzano A, Casado A. Marquina G, et al. Curr Oncol Rep. 2018 Apr 2;20(5):40. doi: 10.1007/s11912-018-0680-3. Curr Oncol Rep. 2018. PMID: 29611060 Review.
Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women throughout the world. ...Platinum-based chemotherapy has been the backbone treatment of metastatic cervical cancer for years with no major outstanding improvemen …
Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women throughout the world. ...Platinum-b …
Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review.
Saei Ghare Naz M, Kariman N, Ebadi A, Ozgoli G, Ghasemi V, Rashidi Fakari F. Saei Ghare Naz M, et al. Asian Pac J Cancer Prev. 2018 Apr 25;19(4):875-884. doi: 10.22034/APJCP.2018.19.4.875. Asian Pac J Cancer Prev. 2018. PMID: 29693331 Free PMC article. Review.
Background: Cervical cancer is the second most common cancer in women worldwide; early detection can play a key role in reducing the associated morbidity. The objective of this study was to systematically assess the effects of educational interventions on …
Background: Cervical cancer is the second most common cancer in women worldwide; early detection can play a key role in …
Cervical cancer: Screening, management, and prevention.
Wuerthner BA, Avila-Wallace M. Wuerthner BA, et al. Nurse Pract. 2016 Sep 22;41(9):18-23. doi: 10.1097/01.NPR.0000490390.43604.5f. Nurse Pract. 2016. PMID: 27513347
Screening for this cancer with Pap test and adjunct human papillomavirus testing has made cervical cancer a treatable disease. This article reviews screening, treatment recommendations, and prevention for cervical cancer....
Screening for this cancer with Pap test and adjunct human papillomavirus testing has made cervical cancer a treatable d …
Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes.
Musselwhite LW, Oliveira CM, Kwaramba T, de Paula Pantano N, Smith JS, Fregnani JH, Reis RM, Mauad E, Vazquez FL, Longatto-Filho A. Musselwhite LW, et al. Acta Cytol. 2016;60(6):518-526. doi: 10.1159/000452240. Epub 2016 Nov 9. Acta Cytol. 2016. PMID: 27825171 Review.
Many elements contribute to racial/ethnic disparities in the cervical cancer continuum - from screening and diagnosis to treatment and outcome. ...Recent studies suggest that racial/ethnic differences in HPV infection exist and may also have a role in observed diffe …
Many elements contribute to racial/ethnic disparities in the cervical cancer continuum - from screening and diagnosis to treat …
Molecular imaging in cervical cancer.
Khan SR, Rockall AG, Barwick TD. Khan SR, et al. Q J Nucl Med Mol Imaging. 2016 Jun;60(2):77-92. Epub 2016 Feb 9. Q J Nucl Med Mol Imaging. 2016. PMID: 26859085 Free article. Review.
Despite the development of screening and of a vaccine, cervix cancer is a major cause of cancer death in young women worldwide. ...The use of molecular imaging techniques, FDG PET/CT and functional MRI, in staging and response assessment of cervical cancer …
Despite the development of screening and of a vaccine, cervix cancer is a major cause of cancer death in young women worldwide …
110,689 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page